Satori Neuro is led by chief investment officer Dr. Amy Kruse, who has more than 20 years of experience in science, technology, and innovation, with a special focus on neurotechnology and human performance.  Satori’s principals have significant operating experience in building and managing successful companies.  Combined, our team’s unique expertise, experience, and relationships give us a distinct advantage in recognizing the most promising and innovative businesses in the sector.